Best CGM for Non Diabetics: OTC Options for Prediabetes & Type 2

Introduction to OTC CGMs

The best CGM for non diabetics now includes over-the-counter options cleared by the FDA in 2024 for adults 18 and older with prediabetes or type 2 diabetes who manage their condition without insulin. Until recently, continuous glucose monitors were available only by prescription and primarily served people using insulin. These devices—worn on the upper arm for up to 14 days—stream glucose readings to a smartphone app every few minutes, creating a continuous trace that shows how your body responds to food, movement, stress, and sleep.

For someone navigating a new prediabetes diagnosis or adjusting to type 2 diabetes, an OTC CGM offers visibility that a quarterly A1C or occasional fingerstick cannot. Research shows that 60% of metabolically healthy adults spike above 140 mg/dL after high-carb meals, and those spikes often go unnoticed without continuous monitoring. Prediabetes is defined as fasting glucose from 100 to 125 mg/dL or A1C from 5.7% to 6.4%, according to CDC and ADA criteria—ranges where small changes in diet and activity can make measurable differences. An OTC CGM turns those abstract numbers into actionable feedback: you see the glucose curve after breakfast, the dip during a walk, the overnight stability when dinner was lighter.

The market for these devices has grown rapidly. In 2025, there were 18.4 million non-diabetic users of continuous glucose monitors globally, driven by longevity clinics and biohacking communities as well as clinical populations. The three most widely available OTC CGMs in the U.S. as of early 2025 are Dexcom Stelo, Abbott Lingo, and Abbott's Libre Rio (a rebadged version of the Libre 2 sold without prescription). Each offers a slightly different feature set, price point, and app experience, but all share the same core function: a small sensor worn on the back of the upper arm that measures interstitial glucose and transmits readings to your phone.

This guide compares those three systems in detail—accuracy, cost per day, app features, and ease of use—so you can choose the best CGM for non diabetics that fits your routine and budget. We'll also cover who benefits most from OTC CGM use, what the data can and cannot tell you, and how to integrate continuous glucose monitoring into a broader plan with your care team. Whether you're newly diagnosed with prediabetes, managing type 2 without medication, or simply want to understand how your meals affect your glucose, an OTC CGM can provide the real-time context that makes those next steps clearer.

Best CGM for Non Diabetics: Top Three Options Compared

Three over-the-counter continuous glucose monitors currently dominate the non-diabetic space: Dexcom Stelo, Abbott Lingo, and Abbott Libre Rio. Each is FDA-cleared for adults 18 and older who do not use insulin, and each ships directly to your door without a prescription. The differences lie in sensor wear time, app design, subscription structure, and price—so your best choice depends on how you plan to use the data and what you're willing to spend per month.

Dexcom Stelo: 15-Day Sensor, Real-Time Alerts

Dexcom Stelo uses a 15-day sensor applied to the back of the upper arm. The app streams glucose readings every five minutes and can send alerts when your glucose crosses a threshold you set—useful if you want immediate feedback after a meal or during exercise. Stelo is sold as a monthly subscription; two sensors per month (30 days of coverage) typically cost around $99, or roughly $3.30 per day. The device does not require fingerstick calibration, and the adhesive is designed to stay put through showers and moderate activity.

Abbott Lingo: Wellness-Focused, 14-Day Sensor

Abbott Lingo targets the wellness and metabolic-health audience with a 14-day sensor and an app that emphasizes glucose spikes and patterns rather than diabetes-specific ranges. Pricing for Lingo sits between $80 and $150 per month depending on subscription tier and region, translating to roughly $2.65 to $5 per day. The app includes coaching prompts and educational content aimed at users tracking diet, exercise, and sleep impact on glucose. Like Stelo, Lingo does not require a prescription and ships directly.

Abbott Libre Rio: Budget Entry, 14-Day Sensor

Libre Rio is Abbott's lower-cost OTC option, also cleared for adults not on insulin. It uses the same 14-day sensor platform as Lingo but with a simpler app interface and fewer coaching features. Pricing details vary by retailer, but Rio is positioned as the most affordable of the three, often landing under $75 per month in promotional bundles. If your goal is basic glucose visibility without app frills, Rio offers the lowest barrier to entry.

What the Numbers Mean

All three devices report glucose in mg/dL and display a trend arrow showing direction of change. None of these OTC CGMs are approved for insulin dosing—if you take insulin, you need a prescription CGM with tighter accuracy specs. For prediabetes or diet-managed type 2, the goal is pattern recognition: which foods spike you above 140 mg/dL, how long it takes to return to baseline, and whether your fasting glucose creeps upward over weeks. The device you choose won't change those physiology facts, but a clearer app or a lower monthly cost can determine whether you stick with it long enough to learn your patterns.

Who Should Use These CGMs?

OTC continuous glucose monitors are designed for specific populations — primarily adults with prediabetes or type 2 diabetes who are not using insulin. These devices are not a substitute for prescription CGMs in people who require insulin therapy, but they serve a distinct role in early-stage glucose management and lifestyle adjustment.

People with Prediabetes or Early Type 2

If you have been told your A1C is in the prediabetes range (5.7–6.4%) or you have a new type 2 diagnosis and are not yet on insulin, an OTC CGM can show you how specific meals, sleep patterns, and activity levels affect your glucose. The goal is not continuous monitoring indefinitely, but rather a structured trial period to identify personal triggers and test behavior changes.

Experts recommend using CGMs for structured 2–4 week trials to identify personal glucose triggers rather than for indefinite monitoring.[^1] The optimal protocol for non-diabetic CGM use is to wear the device for 4–8 weeks, starting with two weeks of baseline observation followed by systematic food testing.[^2]

What These Devices Can and Cannot Tell You

CGMs can help identify how sleep, stress, food order, and post-meal activity affect glucose levels, but they do not prove that every short glucose rise is harmful.[^3] A spike after a meal is normal physiology; the question is whether your glucose returns to baseline in a reasonable time frame and whether patterns over weeks suggest a need for medication or lifestyle change.

These devices are not appropriate for:

• Anyone using insulin (rapid-acting, basal, or mixed) — prescription CGMs with integrated pump systems and low-glucose alerts are the standard of care
• Diagnosing diabetes — a CGM trace does not replace lab A1C or fasting glucose tests
• Managing acute hyperglycemia or hypoglycemia — OTC CGMs lack the real-time alerts and clinical integration required for insulin adjustment

Who Benefits Most

You are likely a good candidate for an OTC CGM if:

• You have prediabetes or type 2 diabetes without insulin, and you want to see how specific foods or routines affect your glucose
• You are working with your care team on lifestyle changes (diet, exercise, sleep) and want objective feedback on what works
• You have a family history of diabetes and want to understand your glucose response before a formal diagnosis
• You are curious about glucose variability but do not have a medical need for continuous monitoring

The value is in the learning period, not in wearing the sensor forever. Use the data to refine your habits, then confirm your progress with standard lab work and your care team's guidance.

Cost Analysis: Price-Per-Day

Over-the-counter CGMs carry a recurring monthly cost that adds up quickly. Unlike prescription CGMs — which may be covered by insurance for people using insulin — OTC devices are paid entirely out of pocket. Understanding the daily and annual expense helps you decide whether continuous monitoring fits your budget, or whether periodic finger-stick testing makes more sense for your situation.

Monthly and Daily Breakdown

Most OTC CGMs are sold as monthly subscriptions or bundles of two-week sensors. Abbott Freestyle Libre Lingo, for example, is priced between $80 and $150 per month depending on the retailer and subscription tier. At the lower end, that works out to roughly $2.67 per day; at the higher end, $5 per day. Over a full year, you're looking at $960 to $1,800 — a significant line item if you're managing prediabetes or type 2 without insulin and paying entirely on your own.

Dexcom Stelo and Abbott Lingo follow similar pricing models, typically landing in the $90–$120 range per month when purchased through a subscription. One-time sensor purchases — buying a two-week sensor individually rather than committing to a monthly plan — often cost more per unit, so the subscription route usually offers the best per-day rate if you plan to wear the device continuously.

Long-Term Savings and Trade-Offs

If you're considering a CGM to guide food choices and activity during prediabetes, compare the annual cost against the potential savings from avoiding progression to type 2 diabetes. Medications like metformin or GLP-1 receptor agonists — often prescribed once A1C crosses into the diabetes range — carry their own monthly costs, copays, and side-effect management. A CGM used for six months to establish stable eating patterns may cost less over time than years of medication, though that calculation depends entirely on your insurance coverage and how effectively you use the data.

For people already diagnosed with type 2 who are not on insulin, the value proposition is trickier. If your A1C is stable on metformin or lifestyle changes alone, periodic lab testing every three to six months may be sufficient. A CGM shines when you're actively experimenting — testing how different meals, exercise timing, or sleep patterns affect your glucose — but once you've learned those patterns, you may not need continuous monitoring year-round. Some users wear a sensor for a month every quarter to check in, then go back to occasional finger sticks, bringing the annual cost down to $300–$500 instead of $1,200+.

Insurance and Reimbursement Realities

As of 2025, Medicare and most private insurers do not cover OTC CGMs for people who do not use insulin. The FDA's over-the-counter designation explicitly removes the prescription requirement, which also removes the pathway for traditional insurance claims. If you have type 2 diabetes and your doctor prescribes intensive insulin therapy, you may qualify for a prescription CGM like FreeStyle Libre 2 or Dexcom G7 under your plan's durable medical equipment benefit — but those devices are not the same as the OTC versions reviewed here, and they require prior authorization and often a copay.

Some employers offer wellness incentives or health savings account (HSA) contributions that can be applied to OTC CGMs if the device is deemed medically necessary. Ask your benefits administrator whether a letter from your primary care provider stating that glucose monitoring supports your prediabetes management would make the expense eligible. The answer varies widely by plan.

The cheapest CGM is the one you actually use long enough to change a habit — a $100 device that sits in a drawer delivers zero value.

Conclusion and Recommendations

Over-the-counter CGMs like Stelo, Lingo, and Libre Rio have opened continuous glucose monitoring to people with prediabetes and type 2 diabetes who don't use insulin—no prescription required. Each device offers real-time glucose data, multi-day wear, and smartphone integration, making it easier to see how food, activity, and sleep affect your numbers. The differences come down to cost, wear time, and whether you want coaching bundled with the sensor.

Stelo is the most affordable option at around $3.33 per day for a 15-day sensor, and it's the only one FDA-cleared specifically for people with type 2 diabetes not on insulin. Lingo costs more—approximately $5.71 per day for a 14-day sensor—but includes built-in coaching and a "Glucose Spike" scoring system designed for behavior change. Libre Rio sits in the middle at roughly $4.29 per day for a 14-day sensor, offering the same core sensor technology as the prescription FreeStyle Libre but packaged for over-the-counter use.

When choosing the best CGM for non diabetics in your situation, start with your primary goal. If you're working to prevent progression from prediabetes to type 2 diabetes and want the lowest daily cost, Stelo is a strong starting point. If you value structured feedback and are willing to pay extra for guided insights, Lingo's coaching model may help you build sustainable habits. And if you want a middle-ground option with proven sensor accuracy and no subscription pressure, Libre Rio offers flexibility.

Remember that CGM data is a tool, not a diagnosis. Research shows that people using CGMs tend to reduce simple carbohydrate intake and increase post-meal activity, but the correlation between short-term glucose fluctuations and long-term markers like A1C is weaker than many assume. Use the real-time feedback to guide daily decisions—what to eat before a meeting, when to take a walk, how different foods affect your energy—but bring the patterns you notice to your next appointment rather than adjusting medications or making major treatment changes on your own.

If cost is a barrier, check whether your insurance plan or HSA/FSA covers any of these devices; some plans have started adding OTC CGMs to their formularies. If you're paying out of pocket, calculate the monthly commitment before you start: Stelo runs about $100 per month, Lingo closer to $170, and Libre Rio around $129. For many people, a three-month trial is enough to identify the habits that move their numbers and build a routine that sticks even after the sensor comes off.

The best CGM for non diabetics is the one you'll actually wear and use to make changes that matter. Start with the device that fits your budget and your learning style, track what you learn, and share that data with your care team. Continuous glucose monitoring isn't magic, but when paired with clear goals and clinical guidance, it can turn abstract advice—"eat better, move more"—into specific, personalized actions you can see working in real time.